Fluidigm Secures Licenses To Key Inventions For Detecting Fetal Genetic Characteristics In Maternal Plasma
Fluidigm Corporation today announced that it has secured co-exclusive licenses to Stanford University inventions that detect fetal genetic characteristics in maternal plasma, including the use of a combination of digital PCR* and high-throughput sequencing.
More: continued here
Filed under: Genetics on December 4th, 2008